ICD-10-CM Billable Code

Z16.29

Resistance to other single specified antibiotic

Clinical Classification Guidelines

Inclusion Terms

  • Resistance to aminoglycosides
  • Resistance to macrolides
  • Resistance to sulfonamides
  • Resistance to tetracyclines

Medical Intelligence & Overview

ICD-10 code Z16.29 refers to the clinical condition where a bacterial infection shows resistance to a specific antibiotic that isn't classified under common categories. This resistance makes treating infections more challenging because standard antibiotics are less effective or ineffective. The code encompasses resistance to various antibiotics, including aminoglycosides, macrolides, sulfonamides, and tetracyclines. Recognizing this resistance helps healthcare providers choose suitable alternative treatments and track antibiotic resistance trends.

Causes & Symptoms

Clinical Causes: Prolonged or repeated use of a particular antibiotic, leading bacteria to develop resistance Inappropriate antibiotic prescribing or misuse by patients Environmental factors contributing to the spread of resistant bacteria Transfer of resistance genes between bacteria via plasmids and other mechanisms Overuse of antibiotics in agriculture and livestock Incomplete courses of antibiotic therapy, allowing bacteria to survive and adapt

Key Symptoms: Persistent or recurrent infection symptoms despite antibiotic treatment Infections that fail to respond to standard therapies Progression of the infection or worsening symptoms despite antibiotic use Possible increase in severity or duration of illness Signs vary depending on the type and location of the infection

Diagnostic & Treatment

Diagnosis Path: Diagnosing antibiotic resistance involves clinical assessment coupled with laboratory testing. Typically, a healthcare provider will perform bacterial cultures from the infected site, followed by antibiotic susceptibility testing. These tests determine which antibiotics are effective against the bacteria, guiding appropriate treatment decisions. Molecular testing may also be used to identify specific resistance genes present in bacterial strains.

Treatment Protocols: Managing infections with antibiotic resistance requires tailored approaches. Alternatives may include using different classes of antibiotics that the bacteria are susceptible to, combination therapy, or adjunctive treatments. In some cases, clinicians may recommend supportive care to help the patient recover. Efforts to prevent the spread of resistant bacteria involve strict infection control practices, judicious use of antibiotics, and ongoing surveillance to monitor resistance patterns.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Z16.29 a billable ICD-10 code?
Yes, Z16.29 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Z16.29?
Clinical documentation must specify the nature of Resistance to other single specified antibiotic and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

single antibiotic resistance